Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. A closely watched clinical trial testing what could be the world’s first ...
Expert Rev Vaccines. 2008;7(9):1341-1356. © 2008 Expert Reviews Ltd. The authors have no relevant affiliations or financial involvement with any organization or ...
Tuberculosis, or TB, an airborne bacterial respiratory infection, is one of humanity's oldest foes and is today the world's leading cause of death from infectious disease, claiming more than 1.2 ...
Bacille Calmette-Guérin (BCG) revaccination didn't help prevent sustained Mycobacterium tuberculosis infection in initially uninfected adolescents without HIV in a randomized trial from South Africa.
A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world's deadliest infectious disease. In the new study, a team ...
A century after the discovery of the original tuberculosis vaccine, scientists have developed a potential game-changer in the fight against one of the world’s oldest and deadliest infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results